Patent · US Active

Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonists

US8633214B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignee

NeRRe Therapeutics Limited · GB

Inventors

Giuseppe Alvaro · Stevenage, GB
Emiliano Castiglioni · Verona, IT
Agostino Marasco · Verona, IT

Key dates

Filing date	Nov 21, 2012
Grant date	Jan 21, 2014
Priority date	—
Expiry date	Nov 21, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) or pharmaceutically acceptable salts thereofprocesses for their preparation, compositions containing them, and uses thereof in the treatment of diseases and conditions for which antagonism of NK1 is beneficial.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.